PGL 0.00% 85.0¢ prospa group limited.

kyou sound familiarnot related to tobago/tharlow...?Bayer says...

  1. 701 Posts.
    k
    you sound familiar

    not related to tobago/tharlow...?

    Bayer says Nexavar phase III skin cancer tests fail to meet primary endpoint

    bayer LEVERKUSEN, Germany (AFX) - Bayer (nyse: BAY ) AG and Onyx Pharmaceuticals Inc said Phase III skin cancer tests of their Nexavar (sorafenib) tablets failed to meet their primary endpoint of improving progression-free survival (PFS).
 
watchlist Created with Sketch. Add PGL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.